GAMMA Investing’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.4K Buy
2,777
+422
+18% +$10.8K ﹤0.01% 2209
2026
Q2
$52.9K Sell
2,355
-340
-13% -$9.51K ﹤0.01% 2258
2026
Q1
$98.7K Buy
2,695
+33
+1% +$1.3K ﹤0.01% 1688
2025
Q4
$121K Buy
2,662
+220
+9% +$9.8K 0.01% 1431
2025
Q3
$103K Buy
2,442
+245
+11% +$9.23K 0.01% 1492
2025
Q2
$68.3K Buy
2,197
+49
+2% +$1.33K ﹤0.01% 1705
2025
Q1
$52.8K Sell
2,148
-624
-23% -$17.3K ﹤0.01% 1756
2024
Q4
$79.3K Buy
2,772
+497
+22% +$13.8K 0.01% 1288
2024
Q3
$60.6K Buy
2,275
+357
+19% +$9.28K 0.01% 1351
2024
Q2
$49.2K Buy
1,918
+104
+6% +$2.33K 0.01% 1208
2024
Q1
$38.4K Buy
1,814
+505
+39% +$9.4K 0.01% 1205
2023
Q4
$21.9K Buy
+1,309
New +$20.4K 0.01% 1436

Other funds holding AORT

GAMMA Investing's AORT Position: Q3 2026 in Review

GAMMA Investing increased its Artivion (AORT) stake by 18% in Q3 2026, buying an estimated $10.8K and bringing the position to 2,777 shares worth $63.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

GAMMA Investing first reported a position in AORT in Q4 2023 and has held it in 12 quarters since. The position peaked at $121K in Q4 2025. 7 funds tracked by Wall St. Rank hold AORT as of Q3 2026.

  • GAMMA Investing held 2,777 shares of Artivion worth $63.4K as of Q3 2026.
  • GAMMA Investing bought 422 Artivion shares in Q3 2026, an estimated $10.8K.
  • Artivion made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2209 holding.
  • GAMMA Investing first reported a position in Artivion in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Artivion position peaked at $121K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Artivion as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.